Melanogenesis itself—and particularly its highly reactive intermediates—exhibits cytotoxic, genotoxic, and mutagenic activities, and can induce glycolysis and activation of hypoxia-inducible factor 1-alpha (HIF-1α); this, combined with its immunosuppressive effects, may promote melanoma progression and resistance to immunotherapy [13]. This evidence concerns the gene HIF1A and melanoma.